Stroke, Major Bleeding and Mortality Outcomes in Warfarin Users with Atrial Fibrillation and Chronic Kidney Disease: A Meta-analysis of Observational Studies.
Conclusions: Based on this meta-analysis, the use of warfarin for AF may have an unfavorable risk/benefit ratio in patients with end-stage CKD but not in those with non-end stage CKD.
PMID: 26378611 [PubMed - as supplied by publisher]
Source: Chest - Category: Respiratory Medicine Authors: Dahal K, Kunwar S, Rijal J, Schulman P, Lee J Tags: Chest Source Type: research
More News: Atrial Fibrillation | Bleeding | Chronic Kidney Disease | Coumadin | Databases & Libraries | Ischemic Stroke | Respiratory Medicine | Stroke | Study | Thrombosis | Urology & Nephrology | Warfarin